News

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...
The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...
Larry Hogan speaks to members of the media at the AstraZeneca facility in Gaithersburg, Md., on Aug. 26, 2024. Larry Hogan ...
The facility is part of AstraZeneca's $3.5 billion investment in U.S. research and manufacturing.
AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...
AstraZeneca opens a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating ...
The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...
As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...
The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.
Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to attack cancer. Soon, Maryland will be home to one of the largest facilities ...
Maryland Lt. Gov. Aruna Miller and other state officials cut the ribbon at a new AstraZeneca facility in Rockville Monday.